The international neuroblastoma risk groups (INRG): A preliminary report

European Journal of Cancer

Volumn 33, Issue 12, 1997, Pages 2113-2116

  Castleberry, R P ^a   Pritchard, J ^a   Ambros, P ^a   Berthold, F ^a   Brodeur, G M ^a   Castel, V ^a   Cohn, S L ^a   De Bernardi, B ^a   Dicks Mireaux, C ^a   Frappaz, D ^a   Haase, G M ^a   Haber, M ^a   Jones, D R ^a   Joshi, V V ^a   Kaneko, M ^a   Kemshead, J T ^a   Kogner, P ^a   Lee, R E J ^a   Matthay, K K ^a   Michon, J M ^a   Monclair, R ^a   Roald, B R ^a   Seeger, R C ^a   Shaw, P J ^a   Shimada, H ^a   Shuster, J J ^a   more..

^a Intl Neuroblastoma Working Grp S   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER DIAGNOSIS; CANCER SCREENING; CHILDHOOD CANCER; CONFERENCE PAPER; HUMAN; NEUROBLASTOMA; PRIORITY JOURNAL; RISK FACTOR; SURVIVAL RATE;

DATABASES, FACTUAL; HUMANS; INFANT; NEOPLASM STAGING; NEUROBLASTOMA; PROGNOSIS; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; RISK FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 0031409775     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(97)00202-5     Document Type: Conference Paper

References (20)

1. Brodeur GM, Castleberry RP. Neuroblastoma. In Pizzo PA, Poplack DG, eds. Principles and Practice of Pediatric Oncology, Philadelphia, PA, Lippincott, 1993, 739-767.
2. Brodeur GM, Seeger RC, Barrett A, et al. International criteria for diagnosis, staging, and response to treatment in patients with neuroblastoma. J Clin Oncol 1988, 6, 1874-1881.
3. Evans A. E., D'Angio G. J., Randolph J. A. A proposed staging for children with neuroblastoma. Children's Cancer Study Group A. Cancer. 27:1971;374-378.
4. Hayes FA, Green AA, Hustu HO, et al. Surgicopathologic staging of neuroblastoma: prognostic significance of regional lymph node metastases. J Pediatr 1983, 102, 59-62.
5. Hartmann D., Scopinaro M., Tournade D. Neurblastomes traites a l'Institut Gustave-Roussy de 1975-1979. Cen soixante-treize cas. Arch Fr Pediatr. 40:1983;15-21.
6. American Joint Committee on Cancer. Neuroblastoma. In Manual for Staging of Cancer, 2nd edn. Philadelphia, PA, Lippincott, 1983, 237-239.
7. Carlsen NLT. Clinical staging of neuroblastomas: assessment of the various staging systems. In Pochedly C, ed. Neuroblastoma: Tumor Biology and Therapy. Boca Raton, FL, CRC Press, 1990, 199-228.
8. Brodeur GM, Pritchard J, Berthold F, et al. Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment. J Clin Oncol 1993, 11, 1466-1477.
9. Castleberry R. P., Shuster J. J., Smith I. E. The Pediatric Oncology Group experience with the International Neuroblastoma Staging System. J Clin Oncol. 1:1994;2378-2381.
10. Hasse GM, Atkinson JB, Stram DO, et al. Surgical management and outcome of locoregional neuroblastoma: comparison of the Children's Cancer Group and international staging systems. J Pediatr Surg 1995, 30, 289-294.
11. Beckwith J. B., Martin R. F. Observations on the histopathology of neuroblastomas. J Pediatr Surg. 3:1968;106-111.
12. Hughes M., Marsden H. B., Palmer M. K. Histologic patterns of neuroblastoma related to prognosis and clinical staging. Cancer. 34:1974;1706-1711.
13. Ota K, Shimizu K. Committee on the histological classification of childhood tumours. In Society JP, ed. Histological Classification and Atlas of Tumours in Infancy and Childhood. Tokyo, Kanahara, 1980.
14. Oppedal BR, Storm-Mathisen I, Lie SO, et al. Prognostic factors in neuroblastoma. Clinical, histopathologic immunohistochemical features and DNA ploidy in relation to prognosis. Cancer 1988, 72, 772-779.
15. Shimada H, Chatten J, Newton WA, et al. Histopathologic prognostic factors in neuroblastic tumors: definition of subtypes of ganglioneuroblastoma and an age-linked classification of neuroblastomas. J Natl Cancer Inst 1984, 73, 405-413.
16. Joshi V, Cantor A, Altshuler G, et al. Age-linked prognostic categorization based on a new grading system of neuroblastomas. Cancer 1992, 69, 2197-2209.
17. Ciampi A., Hogg S. A., Kates L. Stratification by stepwise regression correspondence analysis and recursive partitioning: a comparison of three methods of survival analysis with covariates. Comput Stat Data Anal. 4:1986;185-204.
18. Shuster JJ, McWilliams NB, Castleberry R, et al. Serum lactate dehydrogenase in childhood neuroblastoma: a Pediatric Oncology Group recursive partitioning study. Am J Clini Oncol 1992, 15, 295-303.
19. Brodeur G. Neuroblastoma: clinical significance of genetic abnormalities. Cancer Surv. 9:1990;673.
20. Cheung NK, Heller G, Kushner BH, et al. Stage IV neuroblastoma more than 1 year of age at diagnosis: major response to chemotherapy and survival durations correlated strongly with dose intensity. Prog Clin Biol Res 1991, 3, 567-573.